calcimedica inc glp-1 receptor agonist weight management diabetes treatments Obesity Treatment: What Clinicians Must Know A Comprehensive Review of the

10.1016/j.cmet.2015.08.001 29 KenakinT

The study found the GLP-1 group had significantly better survival and lower risk of AFib when compared to matched patients in the control group

Refractory cases to the previously mentioned approaches would need surgical intervention, that is, cerebrospinal fluid (CSF) shunting or optic nerve sheath fenestration might be the answer

Russia Italy Spain Netherlands Rest of Europe Asia Pacific China Japan India New Zealand Australia South Korea Taiwan Rest of Asia Pacific The Middle East & Africa Saudi Arabia UAE Egypt Kuwait South Africa Rest of the Middle East & Africa Latin America Brazil Argentina Rest of Latin America Competitive Landscape The market is characterized by intense competition among established players and emerging companies

Results When comparing 68 patients on acetazolamide alone to 11 patients on combined therapy with acetazolamide and GLP-1 agonists, no significant differences were found in any of the parameters: papilledema grade, best corrected visual acuity (BCVA), visual field (VF) or OCT RNFL thickness improvements over a 12-month period

Coverage restrictions and high out-of-pocket costs